TrialBeacon
EUClinicalTrials.govClinical trialNot applicableRecruiting

CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA)

Open the official recordBack

Official record

Identifier
NCT07809659
Recruiting locations

countries

CzechiaGreeceLithuaniaPortugal
Interventions studied
CanRiskStandard clinical risk assessment
Lead sponsor
Instituto Portugues Oncologia de Lisboa Francisco Gentil
Target enrolment
2130 participants
Study type
INTERVENTIONAL
Phase
Not applicable
Status
Recruiting
First posted
Sep 9, 2026
Last updated on the registry
Sep 29, 2026
Age
18 Years – 75 Years
Sex
FEMALE
Study contact
The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

1. Women, trans men, non-binary people with female reproductive organs
2. Aged 18 to 75 years
3. Referred or self-referred because of a family history suggestive of increased risk for ovarian, fallopian tube or peritoneum cancer, or because a family member has been found to have a PV associated with OC risk
4. Able to give informed consent
5. Expected to remain in the study catchment area for the duration of follow-up.

Exclusion Criteria:

1. Personal history of cancer
2. Previously undergone Risk-Reducing Salpingo-Oophorectomy (RRSO)
3. Previously undergone multifactorial risk assessment (using CanRisk or another tool) incorporating risk factors, family history and genetic testing (panel +/- PGS)
4. Any condition or circumstance that, in the opinion of the investigator, could interfere with the participant's ability to participate or comply with study requirements
Indexed under
Ovarian Cancer